AllianceBernstein’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
269,203
+31,700
+13% +$155K ﹤0.01% 2324
2026
Q1
$2.13M Buy
237,503
+8,414
+4% +$46.9K ﹤0.01% 1961
2025
Q4
$2.05M Buy
229,089
+20,500
+10% +$127K ﹤0.01% 1990
2025
Q3
$772K Buy
208,589
+11,200
+6% +$30.5K ﹤0.01% 2464
2025
Q2
$385K Hold
197,389
﹤0.01% 2794
2025
Q1
$347K Hold
197,389
﹤0.01% 2711
2024
Q4
$525K Hold
197,389
﹤0.01% 2618
2024
Q3
$452K Hold
197,389
﹤0.01% 2708
2024
Q2
$576K Buy
197,389
+5,185
+3% +$15.8K ﹤0.01% 2597
2024
Q1
$700K Sell
192,204
-7,580
-4% -$14.6K ﹤0.01% 2435
2023
Q4
$302K Sell
199,784
-3,000
-1% -$3.86K ﹤0.01% 2838
2023
Q3
$272K Buy
202,784
+5,570
+3% +$9.27K ﹤0.01% 2845
2023
Q2
$355K Buy
197,214
+17,020
+9% +$28.9K ﹤0.01% 2795
2023
Q1
$299K Buy
180,194
+4,800
+3% +$9.73K ﹤0.01% 2774
2022
Q4
$337K Buy
175,394
+12,400
+8% +$25.1K ﹤0.01% 2822
2022
Q3
$365K Hold
162,994
﹤0.01% 2785
2022
Q2
$528K Hold
162,994
﹤0.01% 2661
2022
Q1
$857K Sell
162,994
-8,200
-5% -$46.1K ﹤0.01% 2480
2021
Q4
$1.46M Buy
171,194
+121,094
+242% +$1.11M ﹤0.01% 2313
2021
Q3
$498K Sell
50,100
-4,100
-8% -$37.2K ﹤0.01% 2759
2021
Q2
$505K Buy
+54,200
New +$618K ﹤0.01% 2807

Other funds holding NUVB

AllianceBernstein's NUVB Position: Q2 2026 in Review

AllianceBernstein increased its Nuvation Bio (NUVB) stake by 13% in Q2 2026, buying an estimated $155K and bringing the position to 269,203 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

AllianceBernstein first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.13M in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • AllianceBernstein held 269,203 shares of Nuvation Bio worth $1.15M as of Q2 2026.
  • AllianceBernstein bought 31,700 Nuvation Bio shares in Q2 2026, an estimated $155K.
  • Nuvation Bio made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2324 holding.
  • AllianceBernstein first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • AllianceBernstein's Nuvation Bio position peaked at $2.13M in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.